Register Login
Register to leave comments
  • News bot May 4, 2026, 11:07 a.m.

    📋 BIOCRYST PHARMACEUTICALS INC (BCRX) - Clinical Trial Update

    Filing Date: 2026-05-04

    Accepted: 2026-05-04 07:06:53

    Event Type: Clinical Trial Update

    Event Details:

    BIOCRYST PHARMACEUTICALS INC (BCRX) Announces Clinical Trial Update BIOCRYST PHARMACEUTICALS INC (BCRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: angioedema, navenibart
    • Diseases/Conditions: hereditary angioedema (HAE) in Europe, hereditary angioedema
    • Clinical Stage: Phase 3 program, Phase 3
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: GLOBE NEWSWIRE

    🔬 Clinical Development Pipeline (BIOCRYST PHARMACEUTICALS INC):

    Product Type Development Stage Therapeutic Area Source
    BCX7353 Other Phase PHASE2 Hereditary Angioedema ClinicalTrials.gov
    BCX10013 Other Phase PHASE1 Paroxysmal Nocturnal Hemoglobinuria ClinicalTrials.gov
    BCX4208 Other Phase PHASE2 Gout ClinicalTrials.gov
    Allopurinol Other Phase PHASE2 Gout ClinicalTrials.gov
    Placebo Other Phase PHASE2 Gout ClinicalTrials.gov
    ulodesine Other Phase PHASE2 Gout ClinicalTrials.gov
    BCX4161 Other Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    Placebo Comparator Other Phase PHASE3 Influenza ClinicalTrials.gov
    Peramivir Other Phase PHASE3 Influenza ClinicalTrials.gov
    Placebo to match BCX7353 Other Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    avoralstat Other Phase PHASE3 Hereditary Angioedema ClinicalTrials.gov
    BCX7353 and probes Other Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    Oseltamivir Other Phase PHASE3 Influenza ClinicalTrials.gov
    Galidesivir Other Phase PHASE1 COVID-19 ClinicalTrials.gov
    BCX9930 Other Phase PHASE1 Paroxysmal Nocturnal Hemoglobinuria ClinicalTrials.gov
    Placebo oral capsule Other Phase PHASE3 Hereditary Angioedema ClinicalTrials.gov
    BCX7353 capsules Other Phase PHASE3 Hereditary Angioedema ClinicalTrials.gov
    BCX9930 monotherapy Drug Phase PHASE2 Paroxysmal Nocturnal Hemoglobinuria (PNH) ClinicalTrials.gov
    Ravulizumab Other Phase PHASE2 Paroxysmal Nocturnal Hemoglobinuria (PNH) ClinicalTrials.gov
    Eculizumab Other Phase PHASE2 Paroxysmal Nocturnal Hemoglobinuria (PNH) ClinicalTrials.gov
    berotralstat Other Phase PHASE3 Hereditary Angioedema ClinicalTrials.gov
    BCX17725 Other Phase PHASE1 Netherton Syndrome ClinicalTrials.gov
    BTA-C585 matching placebo DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    BTA-C585 oral capsules DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    Vapendavir 132 mg capsules DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Vapendavir 300 mg tablet DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Vapendavir DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Cyclosporine + BCX7353 DRUG Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    rosuvastatin + BCX7353 DRUG Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    Rosuvastatin DRUG Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    BCX7353 + digoxin DRUG Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    Digoxin DRUG Phase PHASE1 Hereditary Angioedema ClinicalTrials.gov
    BCX4430 DRUG Phase PHASE1 Filovirus Infections ClinicalTrials.gov
    Ulodesine (BCX4208) 10 mg DRUG Phase PHASE2 Gout ClinicalTrials.gov
    Ulodesine (BCX4208) 5 mg DRUG Phase PHASE2 Gout ClinicalTrials.gov
    Placebo+SOC DRUG Phase PHASE3 Cough ClinicalTrials.gov
    Peramivir+SOC DRUG Phase PHASE3 Cough ClinicalTrials.gov
    forodesine HCl DRUG Phase PHASE2 Chronic Lymphocytic Leukemia (CLL) ClinicalTrials.gov
    Forodesine 200 mg DRUG Phase PHASE2 Cutaneous T-cell Lymphoma (CTCL), ClinicalTrials.gov
    Peramivir 300mg DRUG Phase PHASE3 Influenza ClinicalTrials.gov
    Peramivir 150mg DRUG Phase PHASE3 Influenza ClinicalTrials.gov
    Peramivir 400 mg DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Peramivir 200 mg DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Peramivir 300 mg DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Peramivir 150 mg DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Forodesine Hydrochloride Capsules (100 mg) DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Forodesine Hydrochloride Sterile Solution, 5 mg/mL DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    forodesine hydrochloride (BCX-1777) DRUG Phase PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    forodesine hydrochloride DRUG Phase PHASE1 Lymphoma ClinicalTrials.gov
    BCX-1777 DRUG Phase PHASE1 Leukemia, Lymphocytic ClinicalTrials.gov
    Peldesine DRUG Phase PHASE1 HIV Infections ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOCRYST PHARMACEUTICALS INC
    • Ticker Symbol: BCRX

Search

News categories